✦ LIBER ✦

Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles

✍ Scribed by Paul J. Anderson

Book ID: 113899678
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 177 KB
Volume: 34
Category: Article
ISSN: 0049-0172
DOI: 10.1016/j.semarthrit.2005.01.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of differential immunogenicit

Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors

✍ Paul Anderson; James Louie; Anna Lau; Michael Broder 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 300 KB

Distinct mechanisms of action of tumor n

Distinct mechanisms of action of tumor necrosis factor antagonists: What are the clinical implications?

✍ William F.C. Rigby 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The Toxic Effects of Tumor Necrosis Fact

The Toxic Effects of Tumor Necrosis Factor in vivo and Their Prevention by Cyclooxygenase Inhibitors

✍ Isis C. Kettelhut, Walter Fiers and Alfred L. Goldberg 📂 Article 📅 1987 🏛 National Academy of Sciences 🌐 English ⚖ 847 KB

Individualized monitoring of drug bioava

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

✍ Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C. Kapetan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## Objective Infliximab, an anti–tumor necrosis factor α (anti‐TNFα) antibody, is effective in the treatment of several immunoinflammatory diseases. However, many patients experience primary or secondary response failure, suggesting that individualization of treatment regimens may be b

Different pro-inflammatory profiles of i

Different pro-inflammatory profiles of interleukin 1 (IL 1) and tumor necrosis factor (TNF) in anin vivomodel of inflammation

✍ M. Rampart; W. Fiers; W. Smet; A. G. Herman 📂 Article 📅 1989 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 151 KB

Clinical implications of the tumor necro

Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders : A short review

✍ Anas Younes; Bharat B. Aggarwall 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Abstract Tumor necrosis factor (TNF), originally identified as a factor produced in the serum of endotoxin‐injected animals, is a cytokine that mediates tumor necrosis. To date, 20 different members of the TNF superfamily and 21 different receptors have been identified. All ligands of the TNF su